The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Topic summary

Revisiting: List price versus negotiated price versus what you pay

This is a generated summary. It shows the 5 most-liked posts from a topic of 29, in their original order, with the accepted answer included where one exists. It is a reading aid and it will miss nuance — the full topic is the record.
VK
v.kjaerTL231 Jul 2025#1

Revisiting: List price versus negotiated price versus what you pay — setting out what I have, and where I think it stops being reliable.

Working notes on List price versus negotiated price rather than a conclusion. I would rather post the reasoning while it can still be corrected than post the answer once I am committed to it.

Everything below is checkable. Where I have taken a figure from somewhere else I have said where; where I have estimated, I have said that too.

32 likes 12mo
SD
s.dziedzicTL26 Aug 2025 · edited#13

One caution on List price versus negotiated price: everything above assumes the underlying documentation is what it claims to be. That assumption is doing real work and is rarely stated.

22 likes 12mo
DB
d.barrosTL28 Aug 2025#18
va.baptista, post #11: Adding the measurement that post #8 says would settle it. Cost per milligram is the only comparison that survives format differences, but even then it needs care. A pen and a vial are not the same product and cannot be compared on price per milligram alone because dead volume, wastage, and number of doses actually obtainable differ. I… Go to post

Coming back to post #14, because the follow-up matters more than the original answer.

List prices versus negotiated prices: the price a pharmaceutical company publishes and the price an insurance company or pharmacy actually pays differ substantially. List price is not what anyone pays.

That is all I can say without guessing.

30 likes in reply to #11 12mo
F
FFaulknerTL3Regular9 Aug 2025#21

Answering the question post #20 raises rather than the one it answers.

Pharmacy acquisition cost: a pharmacy pays less than the patient pays, even at insurance rates. That margin is where the pharmacy's costs and profit live.

The interesting part of this is the exception, and I do not understand the exception.

24 likes 12mo
CI
c.inglethorpeTL3Regular10 Aug 2025#25

Price differences within a market are usually about scale, documentation and logistics rather than about anything mysterious.

32 likes 12mo

Read the full topic (29 posts)

Suggested topics

TopicParticipantsRepliesViewsActivity
Why the cheapest option is often not the cheapest
Why the cheapest option is often not the cheapest I have a specific reason for asking rather than idle curiosity, and the context is below. Cheapest option: setting out the arithmetic in full, because I have…
ZIVOTMA+19 23 1.2k 12h
Price changes over 2025 and 2026, tabulated and dated — does this still hold?
Price changes over 2025 and 2026, tabulated and dated — does this still hold? I have a specific reason for asking rather than idle curiosity, and the context is below. Documenting an access outcome, dated,…
WMCCDFKSDO+147 156 18k 3mo
[2026 update] Comparing prices across jurisdictions without misleading yourself
On the subject in the title: Comparing prices across jurisdictions without misleading yourself Working notes rather than a conclusion. Comparing prices across jurisdictions keeps being re-asked here and I…
SDICP 2 809 23h
Price changes over 2025 and 2026, tabulated and dated
Posting this under the heading it deserves: Price changes over 2025 and 2026, tabulated and dated Everything below is what sits behind that. Documenting an access outcome, dated, because everything in this…
MAOCASMIDB+4 8 658 14mo
Second pass at: Manufacturer assistance programmes and their eligibility rules
Second pass at: Manufacturer assistance programmes and their eligibility rules — setting out what I have, and where I think it stops being reliable. Two things I would like separated before anyone answers on…
JDLAPOHNKK+13 17 1.8k 16mo

Related topics — sharing the tags cost per milligram, compounding, data table

TopicParticipantsRepliesViewsActivity
Follow-up: Prior authorisation: what the criteria usually require
Prior authorisation: what the criteria usually require — setting out what I have, and where I think it stops being reliable. A methods question rather than a substantive one, about Prior authorisation.…
BBFDTAZRA+95 100 9.1k 10h
Coming back to: A community side-effect dataset, with its response rate and biases
Posting this under the heading it deserves: A community side-effect dataset, with its response rate and biases Everything below is what sits behind that. Community side-effect dataset — I have the observation…
JRNKNAPMFV+96 101 33k 2d
Enforcement priorities versus written rules — does this still hold?
Enforcement priorities versus written rules — does this still hold? — that is the question, and I have not found it answered plainly anywhere I have looked. Asking what a regulator's document actually says,…
ROOSOCDSV+36 40 37k 11mo
NHS criteria and how they are applied in practice — the long version
Posting this under the heading it deserves: NHS criteria and how they are applied in practice — the long version Everything below is what sits behind that. A narrow question about NHS criteria, deliberately…
RLJIWTGBST+11 15 11k 9mo
Contributing data without breaching anyone's privacy — what changed since
On the subject in the title: Contributing data without breaching anyone's privacy — what changed since Working notes rather than a conclusion. What changes if the standard account of Contributing data without…
RIMSBJ 2 58k 17mo